Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy

This study evaluated the efficacy and safety of adding etanercept to disease-modifying antirheumatic drugs (DMARDs) in patients with moderately active rheumatoid arthritis (RA). This randomized, double-blind, placebo-controlled study (ClinicalTrials.gov #NCT01313208) enrolled RA patients with Diseas...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Springerplus
Main Authors: Hobbs, Kathryn, Deodhar, Atul, Wang, Brian, Bitman, Bojena, Nussbaum, Joyce, Chung, James, Collier, David H
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2015
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4359699/
https://ncbi.nlm.nih.gov/pubmed/25793152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-0895-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki